Dr William Loging
Dr. Loging has spent the past 20 years focusing on generating treatments for human disease. Bridging both clinical genomics and pharmaceutical sciences, he have been globally recognized for his work with Maraviroc (Selzentry™) for use in HIV. The results of past his contribution to the approval of Empagliflozin (Jardiance™) were listed within the drug insert. He has published in several leading scientific journals on utilization of novel informatics approaches to Drug Discovery and his 2014 TEDx talk on Cancer Genomics was highly acclaimed.
23-Jan-2018Genomics- a Silver Bullet